JPRN-UMIN000033409
Completed
Phase 1
Prevention of local skin reaction by heparinoid due to rotigotine transdermal patch: a pilot randomized clinical trial. - SkinHeRo
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Parkinson'
- Sponsor
- Wakayama Medical University
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. severe dementia 2\. severe skin disease 3\. severe allergic reactions to rotigotine or heparinoid 4\. patients who are judged as not suitable for participation in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
To test whether application of topical heparin solution around the IV cannula site daily would reduce the occurrence of superficial inflammation of veins when compared to a placeboHealth Condition 1: I809- Phlebitis and thrombophlebitis ofunspecified siteCTRI/2024/06/069653All India Institute of Medical Sciences, Mangalagiri
Completed
Not Applicable
sefulness of topical heparinoid in the treatment of asteatosis in hemodialyzed patientsasteatosis in hemodialyzed patientJPRN-UMIN000029360ippon medical school hospital76
Recruiting
Not Applicable
Effect of heparin to prevent obstruction of the Hickman® catheterThis research will be performed on the Hickman® catheter inserted in the patients submitted to hematopoietic stem cell transplantation.Central venous catheters, hematopoietic stem cell transplantation.E07.132.750.500E04.936.225.687.500RBR-3ht499Hospital de Clínicas Universidade Federal do Paraná
Completed
Phase 3
Evaluation of the effect of nebulized heparin on days without ventilator in intensive care unit patientsAcute respiratory distress syndrom.Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vaporsJ68.3IRCT20211010052718N2Mazandaran University of Medical Sciences74
Completed
Not Applicable
Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom.JPRN-UMIN000018986Osaka city university graduate school of medicine, department of dermatology50